Regulation of HTT mRNA Biogenesis: The Norm and Pathology

Area of Science:

• Genetics
• Neurodegenerative Diseases
• Molecular Biology

Background:

• Huntington's disease (HD) is a severe, inherited neurodegenerative disorder.
• It is caused by a CAG repeat expansion in the HTT gene, producing toxic huntingtin protein.
• No effective treatments currently exist for HD.

Purpose of the Study:

• To review the transcriptional regulation and processing of HTT mRNA variants.
• To highlight the impact of diverse HTT transcript isoforms on HD pathology.
• To explore the potential of endogenous regulators as therapeutic targets.

Main Methods:

• Review of existing literature on HTT gene regulation and transcript processing.
• Analysis of the role of HTT transcript isoforms in HD pathogenesis.
• Discussion of current RNA-targeted gene therapy approaches for HD.

Main Results:

• The HTT gene produces various mRNA variants through complex transcriptional regulation and processing.
• These diverse isoforms may play unique roles in HD progression.
• Current gene therapy strategies may not fully account for this transcript diversity.

Conclusions:

• Understanding HTT mRNA variant formation is crucial for developing effective HD therapies.
• Targeting diverse HTT isoforms and their regulatory mechanisms offers new therapeutic avenues.
• Endogenous regulators of HTT present potential targets for novel treatment strategies.